EPISODIC MIGRAINE
Clinical trials for EPISODIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new EPISODIC MIGRAINE trials appear
Sign up with your email to follow new studies for EPISODIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily migraine pill safety check: what 441 patients revealed
Disease control CompletedThis study tested the long-term safety of taking rimegepant daily to prevent episodic migraine attacks. Researchers followed 441 adults with frequent migraines for up to a year to monitor side effects and how well they tolerated the medication. The goal was to understand the risk…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Three-Year pill test aims to tame debilitating migraines
Disease control CompletedThis study followed nearly 600 people for three years to check the long-term safety of a daily pill called atogepant, which is designed to prevent migraine attacks. It focused on people who suffer from either chronic (frequent) or episodic (less frequent) migraines. The main goal…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC